HK1203867A1 - Transdermal methods and systems for the delivery of anti-migraine compounds - Google Patents

Transdermal methods and systems for the delivery of anti-migraine compounds Download PDF

Info

Publication number
HK1203867A1
HK1203867A1 HK15104294.8A HK15104294A HK1203867A1 HK 1203867 A1 HK1203867 A1 HK 1203867A1 HK 15104294 A HK15104294 A HK 15104294A HK 1203867 A1 HK1203867 A1 HK 1203867A1
Authority
HK
Hong Kong
Prior art keywords
patch
sumatriptan
delivery
subject
triptan compound
Prior art date
Application number
HK15104294.8A
Other languages
English (en)
Chinese (zh)
Inventor
R. Anderson Carter
L. Morris Russell
B. Sebree Terri
Original Assignee
Teva Pharmaceuticals International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceuticals International Gmbh filed Critical Teva Pharmaceuticals International Gmbh
Publication of HK1203867A1 publication Critical patent/HK1203867A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15104294.8A 2006-04-13 2015-05-06 Transdermal methods and systems for the delivery of anti-migraine compounds HK1203867A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US79181906P 2006-04-13 2006-04-13
US60/791819 2006-04-13
US81413106P 2006-06-16 2006-06-16
US60/814131 2006-06-16

Publications (1)

Publication Number Publication Date
HK1203867A1 true HK1203867A1 (en) 2015-11-06

Family

ID=38610170

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104294.8A HK1203867A1 (en) 2006-04-13 2015-05-06 Transdermal methods and systems for the delivery of anti-migraine compounds

Country Status (13)

Country Link
US (4) US7973058B2 (enExample)
EP (1) EP2012871A4 (enExample)
JP (3) JP5580042B2 (enExample)
CN (2) CN104138634B (enExample)
AU (1) AU2007238685B2 (enExample)
BR (1) BRPI0709965C2 (enExample)
CA (2) CA2935569A1 (enExample)
EA (1) EA023147B1 (enExample)
HK (1) HK1203867A1 (enExample)
IL (1) IL194553A (enExample)
MX (1) MX2008012922A (enExample)
NZ (2) NZ610790A (enExample)
WO (1) WO2007120747A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2935569A1 (en) * 2006-04-13 2007-10-25 Teva Pharmaceuticals International Gmbh Transdermal methods and systems for the delivery of anti-migraine compounds
ES2604968T3 (es) * 2008-04-28 2017-03-10 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
US8155737B2 (en) 2008-06-19 2012-04-10 Nupathe, Inc. Pharmacokinetics of iontophoretic sumatriptan administration
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
AU2009259601B2 (en) 2008-06-19 2014-09-18 Lts Lohmann Therapie-Systeme Ag Composition for transdermal delivery of cationic active agents
US9913806B2 (en) * 2008-06-25 2018-03-13 Fe3 Medical, Inc. Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
CN104043194A (zh) 2008-12-30 2014-09-17 纽帕特公司 离子透入给药系统
US8348922B2 (en) * 2009-02-12 2013-01-08 Incube Labs, Llc Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
US8417330B2 (en) * 2009-06-26 2013-04-09 Incube Labs, Llc Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use
BR112012003111A8 (pt) * 2009-08-10 2017-10-10 Nupathe Inc Métodos para tratar iontoforeticamente náusea e enxaqueca
WO2011044175A2 (en) 2009-10-06 2011-04-14 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
WO2011046927A1 (en) * 2009-10-13 2011-04-21 Nupathe,Inc. Transdermal methods and systems for the delivery of rizatriptan
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
RU2595894C2 (ru) 2010-08-27 2016-08-27 Грюненталь Гмбх Замещенные 2-окси-хинолин-3-карбоксамиды в качестве модуляторов kcnq2/3
HUE024870T2 (en) 2010-08-27 2016-02-29 Gruenenthal Gmbh Substituted 2-oxo and 2-thioxo-dihydroquinoline-3-carboxamides as modulators of KCNQ2 / 3
AU2012230701B2 (en) 2011-03-24 2016-09-29 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US9744353B2 (en) 2012-11-14 2017-08-29 Teva Pharmaceuticals International Gmbh Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device
EP3416618A1 (en) 2016-02-19 2018-12-26 ZP Opco, Inc. Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
GB2554455A (en) 2016-09-29 2018-04-04 Feeligreen Sa Skin treatment device and method for delivery of an active ingredient into the human skin by means of iontophoresis, using an array of electrodes
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
WO2019053051A1 (en) * 2017-09-12 2019-03-21 Lts Lohmann Therapie-Systeme Ag MICRO NEEDLE IONTOPHORESIS DEVICE
US11318292B2 (en) 2018-05-28 2022-05-03 Microneedles Inc. Microneedle patch for transdermal injections
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
JP7687971B2 (ja) 2019-06-28 2025-06-03 パスポート テクノロジーズ、インコーポレイテッド トリプタンマイクロポレーション送達システム
CA3144633A1 (en) * 2019-06-28 2020-12-30 Passport Technologies, Inc. Methods and systems for controlling energy delivery to filament devices
US11364225B2 (en) 2019-08-21 2022-06-21 Bn Intellectual Properties, Inc. Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4856188A (en) 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US4557723A (en) 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US5605536A (en) 1983-08-18 1997-02-25 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US5651768A (en) 1983-08-18 1997-07-29 Drug Delivery Systems, Inc. Transdermal drug applicator and electrodes therefor
US4883457A (en) 1983-08-18 1989-11-28 Drug Delivery Systems Inc. Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same
US5042975A (en) * 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US4822802A (en) 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US4865582A (en) * 1987-06-05 1989-09-12 Drug Delivery Systems Inc. Disposable transdermal drug applicators
US5162042A (en) * 1988-07-05 1992-11-10 Alza Corporation Electrotransport transdermal system
US4927408A (en) 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5207752A (en) * 1990-03-30 1993-05-04 Alza Corporation Iontophoretic drug delivery system with two-stage delivery profile
DE4014913C2 (de) 1990-05-10 1996-05-15 Lohmann Therapie Syst Lts Miniaturisiertes transdermales therapeutisches System für die Iontophorese
JP3488466B2 (ja) 1992-06-02 2004-01-19 アルザ・コーポレーション 電気駆動式薬物投与デバイス
DE4314976C1 (de) * 1993-05-06 1994-10-06 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung
US5807571A (en) * 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
US5458569A (en) 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
PH31437A (en) * 1993-08-27 1998-11-03 Janssen Pharmaceutica Nv Tontophoretic delivery of an antimigrane drug.
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
US5700481A (en) * 1995-03-17 1997-12-23 Takeda Chemical Industries, Ltd. Transdermal drug delivery process
JPH08317997A (ja) * 1995-03-17 1996-12-03 Takeda Chem Ind Ltd 経皮透過方法
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
AU699774B2 (en) 1995-06-05 1998-12-17 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5688232A (en) 1995-09-28 1997-11-18 Becton Dickinson And Company Iontophoretic drug delivery device having an improved controller
US5941843A (en) * 1996-07-12 1999-08-24 Empi, Inc. Iontophoresis electrode
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5882677A (en) * 1997-09-30 1999-03-16 Becton Dickinson And Company Iontophoretic patch with hydrogel reservoir
JP4290271B2 (ja) 1998-04-14 2009-07-01 久光製薬株式会社 経皮透過方法
SE9802864D0 (sv) * 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
EP1170029B1 (en) * 1999-04-12 2009-03-11 Hisamitsu Pharmaceutical Co., Inc. Device for iontophoresis
US6312716B1 (en) * 1999-05-10 2001-11-06 Peierce Management Llc Patch and method for transdermal delivery of bupropion base
US6385488B1 (en) * 1999-05-20 2002-05-07 Vyteris, Inc. Circuits for increasing the reliability of an iontophoretic system
US6421561B1 (en) * 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
AU2001281746C1 (en) * 2000-07-31 2010-09-09 ISTITUTO GENTILI S.r.l. Fentanyl composition for nasal administration
US6653014B2 (en) 2001-05-30 2003-11-25 Birch Point Medical, Inc. Power sources for iontophoretic drug delivery systems
EP1435945B1 (en) * 2001-06-05 2008-08-13 Aung-din, Ronald Topical migraine therapy
CN1606461B (zh) * 2001-10-24 2011-03-23 纸型电池有限公司 一种用制剂作皮肤治疗的装置、一种成套器具及皮肤贴片
CN100352506C (zh) * 2002-02-26 2007-12-05 奥索-麦克尼尔药品公司 抗惊厥剂衍生物和抗偏头痛药物联合的制药用途
JP4191951B2 (ja) 2002-04-25 2008-12-03 ソントル ファルマペプティド 抗微生物剤投与装置および組立品
CA2512854C (en) 2002-06-28 2010-02-09 Alza Corporation A reservoir for use in electrotransport drug delivery
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
RU2326893C2 (ru) 2003-04-16 2008-06-20 Кориум Интернэшнл Ковалентное и нековалентное сшивание гидрофильных полимеров и адгезивные композиции, полученные с ними
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050228336A1 (en) * 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
UY28935A1 (es) 2004-06-03 2005-07-29 Alza Corp Sistema y metodo para la administracion transdermica de un anticoagulante
WO2006015299A2 (en) * 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
US20070093788A1 (en) 2005-09-30 2007-04-26 Darrick Carter Iontophoresis method and apparatus for systemic delivery of active agents
CA2935569A1 (en) * 2006-04-13 2007-10-25 Teva Pharmaceuticals International Gmbh Transdermal methods and systems for the delivery of anti-migraine compounds

Also Published As

Publication number Publication date
JP5580042B2 (ja) 2014-08-27
CA2650412C (en) 2016-09-27
MX2008012922A (es) 2008-12-17
CA2935569A1 (en) 2007-10-25
NZ596498A (en) 2013-05-31
BRPI0709965A2 (pt) 2011-08-02
BRPI0709965C1 (pt) 2011-12-20
WO2007120747A3 (en) 2008-04-24
US20110213294A1 (en) 2011-09-01
US7973058B2 (en) 2011-07-05
AU2007238685B2 (en) 2012-09-13
BRPI0709965C2 (pt) 2011-12-20
US9272137B2 (en) 2016-03-01
CN104138634B (zh) 2016-09-07
JP2016163723A (ja) 2016-09-08
NZ610790A (en) 2015-05-29
CA2650412A1 (en) 2007-10-25
EA023147B1 (ru) 2016-04-29
EP2012871A4 (en) 2015-07-22
US8470853B2 (en) 2013-06-25
AU2007238685A1 (en) 2007-10-25
US20160317464A1 (en) 2016-11-03
IL194553A (en) 2016-03-31
CN104138634A (zh) 2014-11-12
EA200802146A1 (ru) 2009-06-30
WO2007120747A2 (en) 2007-10-25
US20080287497A1 (en) 2008-11-20
EP2012871A2 (en) 2009-01-14
US20110213330A1 (en) 2011-09-01
JP5925844B2 (ja) 2016-05-25
JP2014221798A (ja) 2014-11-27
CN101472644B (zh) 2014-04-23
CN101472644A (zh) 2009-07-01
JP2009533451A (ja) 2009-09-17

Similar Documents

Publication Publication Date Title
US8470853B2 (en) Transdermal methods and systems for the delivery of anti-migraine compounds
Siegel et al. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan
CA2770211A1 (en) Methods for iontophoretically treating nausea and migraine
JP5951741B2 (ja) イオントフォレシスによるスマトリプタン投与の薬物動態
AU2015203213B2 (en) Transdermal methods and systems for the delivery of anti-migraine compounds
AU2012261753B2 (en) Transdermal methods and systems for the delivery of anti-migraine compounds